UB Paderborn / Katalog / Suche / in CDI

Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro

Clinical & experimental metastasis, 1998-02, Vol.16 (2), p.193-203

1998

Volltextzugriff (PDF)

A Covalent Linkage between Daunorubicin and Proteins That is Stable in Serum and Reversible by Lysosomal Hydrolases, as Required for a Lysosomotropic Drug-Carrier Conjugate: In vitro and in vivo Studies

Proceedings of the National Academy of Sciences - PNAS, 1982, Vol.79 (2), p.626-629

1982

Volltextzugriff (PDF)

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer : Application to doxorubicin and preliminary in vitro and in vivo studies

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (7), p.2843-2846

2001

Volltextzugriff (PDF)

Immunological evaluation of blood contamination in tissue distribution studies

Pharmacological research, 1989, Vol.21 (1), p.19-26

1989

Volltextzugriff (PDF)

Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin

Cancer chemotherapy and pharmacology, 1982-01, Vol.8 (2), p.243-249

1982

Volltextzugriff (PDF)

Preclinical assessment of the cardiotoxic potential of anthracycline antibiotics: N-L-leucyl-doxorubicin

Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1991, Vol.14, p.107

1991

Volltextzugriff (PDF)

High dose melphalan in children with advanced malignant disease: a pharmacokinetic study

Cancer chemotherapy and pharmacology, 1985-01, Vol.15 (3), p.263-267

1985

Volltextzugriff (PDF)

Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubules

The Journal of pharmacology and experimental therapeutics, 1984-05, Vol.229 (2), p.372

1984

Volltextzugriff (PDF)

Coupling products of amino acids to penicillin V and cephalothin: synthesis and susceptibility to carboxypeptidases and lysosomal enzymes

Journal of medicinal chemistry, 1988-05, Vol.31 (5), p.976-983

1988

Volltextzugriff (PDF)

Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity of L1210 leukemic cells in vitro and in vivo

Journal of medicinal chemistry, 1980-11, Vol.23 (11), p.1171-1174

1980

Volltextzugriff (PDF)

Development of new derivatives of primaquine by association with lysosomotropic carriers

Bulletin of the World Health Organization, 1981, Vol.59 (3), p.449-458

1981

Volltextzugriff (PDF)

Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice

Cancer chemotherapy and pharmacology, 1979, Vol.2 (1), p.11-14

1979

Volltextzugriff (PDF)

Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography

Analytical biochemistry, 1979-04, Vol.94 (1), p.112-116

1979

Volltextzugriff (PDF)

Bio-analysis of N-(deacetyl- O-4-vinblastoyl-23)- l-ethyl isoleucinate, methane sulphonate (VileE) by high-performance liquid chromatography with fluorescence detection

Journal of pharmaceutical and biomedical analysis, 1990, Vol.8 (8), p.1029-1031

1990

Volltextzugriff (PDF)

Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice

Cancer chemotherapy and pharmacology, 1982-01, Vol.8 (2), p.193

1982

Volltextzugriff (PDF)

Distribution and metabolism of rubidazone and daunorubicin in mice: A comparative study

Cancer chemotherapy and pharmacology, 1979, Vol.2 (1)

1979

Volltextzugriff (PDF)

Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes

Cancer chemotherapy and pharmacology, 1979, Vol.2 (1), p.25

1979

Volltextzugriff (PDF)

DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro

Cancer chemotherapy and pharmacology, 1979, Vol.2 (1), p.7-10

1979

Volltextzugriff (PDF)

Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles

European journal of cancer, 1981-03, Vol.17 (3), p.297-305

1981

Volltextzugriff (PDF)

Photolysis of desmosine and isodesmosine by ultraviolet light

Advances in experimental medicine and biology, 1977, Vol.79, p.177

1977

Volltextzugriff (PDF)

Drug targeting in cancer treatment: active daunorubicin-protein conjugates

Progress in clinical and biological research, 1982, Vol.102 pt A, p.291

1982

Volltextzugriff (PDF)

DNA, liposomes, and proteins as carriers for antitumoral drugs

Recent results in cancer research, 1980, Vol.75, p.229

1980

Volltextzugriff (PDF)

Cellular pharmacology of detorubicin and doxorubicin in L1210 cells

European journal of cancer & clinical oncology, 1984, Vol.20 (1), p.115-121

1984

Volltextzugriff (PDF)

Human pharmacokinetics of N‐l‐leucyl‐doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities

Clinical pharmacology and therapeutics, 1992-03, Vol.51 (3), p.249-259

1992

Volltextzugriff (PDF)

Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion

Journal of medicinal chemistry, 1980-11, Vol.23 (11), p.1166-1170

1980

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro

A Covalent Linkage between Daunorubicin and Proteins That is Stable in Serum and Reversible by Lysosomal Hydrolases, as Required for a Lysosomotropic Drug-Carrier Conjugate: In vitro and in vivo Studies

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer : Application to doxorubicin and preliminary in vitro and in vivo studies

Immunological evaluation of blood contamination in tissue distribution studies

Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin

Preclinical assessment of the cardiotoxic potential of anthracycline antibiotics: N-L-leucyl-doxorubicin

High dose melphalan in children with advanced malignant disease: a pharmacokinetic study

Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubules

Coupling products of amino acids to penicillin V and cephalothin: synthesis and susceptibility to carboxypeptidases and lysosomal enzymes

Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity of L1210 leukemic cells in vitro and in vivo

Development of new derivatives of primaquine by association with lysosomotropic carriers

Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice

Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography

Bio-analysis of N-(deacetyl- O-4-vinblastoyl-23)- l-ethyl isoleucinate, methane sulphonate (VileE) by high-performance liquid chromatography with fluorescence detection

Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice

Distribution and metabolism of rubidazone and daunorubicin in mice: A comparative study

Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes

DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro

Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles

Photolysis of desmosine and isodesmosine by ultraviolet light

Drug targeting in cancer treatment: active daunorubicin-protein conjugates

DNA, liposomes, and proteins as carriers for antitumoral drugs

Cellular pharmacology of detorubicin and doxorubicin in L1210 cells

Human pharmacokinetics of N‐l‐leucyl‐doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities

Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion

Suchergebnisse filtern